Finanztrends
Beximco Pharmaceuticals Ltd. GDR Aktie
Unverändert bleibt der Kurs der Beximco Pharmaceuticals Ltd. GDR Aktie im Vergleich zu gestern.
Was spricht für und gegen Beximco Pharmaceuticals Ltd. GDR in den nächsten Jahren?
Pro
?
W******* i* V********
?
M************
?
U****************
Kontra
?
M****
?
A****************
?
L*********** I********** f** d** n******* J****
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Beximco Pharmaceuticals Ltd. GDR im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Beximco Pharmaceuticals Ltd. GDR | 0,00 % | -26,21 % | -15,18 % | -12,04 % | -15,18 % | -19,15 % | -64,15 % |
| Eledon Pharmaceuticals Inc. | 2,87 % | -5,95 % | 35,94 % | -61,33 % | 35,94 % | -43,14 % | -85,64 % |
| SELLAS Life Sciences Group Inc | 9,42 % | -11,89 % | 12,35 % | 105,75 % | 12,35 % | 4,60 % | -36,83 % |
| Kalbe Farma | 6,12 % | -7,14 % | 70,49 % | -23,53 % | 70,49 % | -46,94 % | 0,00 % |
Kommentare
News
Why Atai Life Sciences Stock Was So Lively This Week
Atai Life Sciences (NASDAQ: ATAI), a biotech focused on developing psychedelic-based medicines to treat mental health disorders, was a standout stock over the past few days in its rather limited
Why Atai Life Sciences Stock Crushed It on Tuesday
Atai Life Sciences (NASDAQ: ATAI), an ambitious biotech that targets mental health disorders, was a hot item among equity investors Tuesday. The company saw its share price rise by just under 15%